The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:

 

General Notices

• Request for Information (RFI): Understanding the Creation, Continuation, and Consequences of Illicit Drug Markets
  (NOT-DA-23-023)
  National Institute on Drug Abuse

• Request for Information (RFI): Food is Medicine Research Opportunities
  (NOT-OD-23-107)
  Office of Nutrition Research
  Agency for Healthcare Research and Quality
  Food and Drug Administration
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  Office of AIDS Research
  Office of the Director, NIH
  Office of Disease Prevention
  Office of Dietary Supplements
  Office of Research on Women's Health

Notice of Changes to Funding Opportunities

• Notice of Early Expiration of PAR-21-112, "Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32)"
  (NOT-AG-23-019)
  National Institute on Aging

• Notice of Change in Funding Opportunity Purpose of NIDCR Small Research Grants for Analyses of Existing Genomics Data (PAR-23-132)
  (NOT-DE-23-009)
  National Institute of Dental and Craniofacial Research

• Notice to update Section IV. Application and Submission Information - Specific Aims and Research Strategy: for PAR-21-178 - Drug Development Tools Research Grants (U01) Clinical Trial Optional
  (NOT-FD-23-009)
  Food and Drug Administration

• Notice to Extend the Application Due Date for RFA-FD-23-019 - Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed
  (NOT-FD-23-010)
  Food and Drug Administration

• Notice to Extend the Application Due Date for RFA-FD-23-027- Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed
  (NOT-FD-23-011)
  Food and Drug Administration

• Notice of Change of the Locus of Review, Application Types Allowed and Expiration date for PAR-23-097, "Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)"
  (NOT-MH-23-205)
  National Institute of Mental Health

• Notice of Change of the Locus of Review for PAR-23-102, "Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)"
  (NOT-MH-23-206)
  National Institute of Mental Health

• Notice of Termination of PAR-22-100 "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
  (NOT-TR-23-008)
  National Center for Advancing Translational Sciences

• Notice of Termination of PAR-22-101 "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
  (NOT-TR-23-009)
  National Center for Advancing Translational Sciences

Notices of Intent to Publish

• Notice of Intent to Publish a Notice of Funding Opportunity for the PATCH-IN Implementation Science Coordinating Center (UM2 Clinical Trial Optional)
  (NOT-HD-23-009)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development

• Notice of Intent to Publish a Notice of Funding Opportunity for Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
  (NOT-HG-23-034)
  National Human Genome Research Institute

• Notice of Intent to Publish a Notice of Funding Opportunity for Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
  (NOT-HG-23-035)
  National Human Genome Research Institute

Notices of Special Interest

• Notice of Special Interest (NOSI): Assembling the Addiction Organelle Interactome
  (NOT-DA-24-007)
  National Institute on Drug Abuse

• Notice of Special Interest (NOSI): NIDCD National Research Service Award (NRSA) T32 and T35 Diversity Administrative Supplement
  (NOT-DC-23-010)
  National Institute on Deafness and Other Communication Disorders

• Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications.
  (NOT-EB-23-002)
  National Institute of Biomedical Imaging and Bioengineering
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of General Medical Sciences

• Notice of Special Interest (NOSI): EXposome in Autoimmune Disease Collaborating Teams PLANning Awards (EXACT-PLAN) (Clinical Trials Not Allowed)
  (NOT-OD-23-112)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Eye Institute
  National Institute on Aging
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  Office of Research on Women's Health

Funding Opportunities

• Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
  (PAR-23-098)
  National Human Genome Research Institute
  National Institute of Mental Health
   
• Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
  (PAR-23-119)
  National Institute of Diabetes and Digestive and Kidney Diseases
   
• Development and Validation of Models for Alzheimers Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed)
  (PAR-23-154)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
   
• Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
  (PAR-23-155)
  National Cancer Institute
   
• Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
  (PAR-23-157)
  National Institute on Drug Abuse
   
• Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required)
  (PAR-23-158)
  National Institute on Drug Abuse
   
• Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
  (PAR-23-159)
  National Center for Advancing Translational Sciences
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
   
• Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
  (PAR-23-160)
  National Center for Advancing Translational Sciences
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
   
• Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
  (PAR-23-163)
  National Institute on Aging
   
• International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
  (RFA-AI-23-023)
  National Institute of Allergy and Infectious Diseases
   
• Strengthening Global Competency and Capacity in Inspectional Approaches for the Oversight of Human and Animal Pharmaceutical Products (U01) Clinical Trials Not Allowed
  (RFA-FD-23-022)
  Food and Drug Administration
   
• Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH) (U01 Clinical Trial Optional)
  (RFA-MH-23-105)
  National Institute of Mental Health
   
• Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH): Data Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-MH-23-106)
  National Institute of Mental Health
   
• BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
  (RFA-MH-23-270)
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
   
• BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required)
  (RFA-MH-23-330)
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
   
• BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
  (RFA-MH-23-331)
  National Institute of Mental Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
   
• Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed)
  (RFA-TR-23-010)
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Neurological Disorders and Stroke
   

Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 313-335-2123, or email Ann Ricketts at ann-ricketts@uiowa.edu or Lynn Hudachek at lynn-hudachek@uiowa.edu.